Full-Time

Senior Biostatistician

Posted on 10/31/2025

Lexitas

Lexitas

51-200 employees

Ophthalmology-focused CRO for clinical trials

Compensation Overview

$150k - $165k/yr

Remote in USA

Remote

Category
Biology & Biotech (2)
,
Requirements
  • Education: Required: Bachelor’s degree or international equivalent in Biostatistics, Statistics, or related field
  • Education: Preferred: Master’s degree or equivalent in Biostatistics, Statistics, or related field
  • Experience: 5 or more years of experience in statistical analysis within clinical research, preferred
  • Skills: Basic understanding of statistical topics and methodology in drug and medical product development
  • Skills: Excellent technical and programming logic skills
  • Skills: Experience with cross-functional collaboration
  • Skills: Excellent verbal and written communication skills
  • Skills: Good planning and organizational skills with the ability to adapt and adjust to changing priorities
  • Skills: Ability to be productive and handle multiple tasks to meet deadlines in a dynamic, fast-paced environment
  • Skills: Strong interest in developing expertise in ophthalmology
  • Physical Requirements: Position requires: ordinary ambulatory skills and physical coordination sufficient to move about conference or meeting locations as required; ability to stand, walk, stoop, kneel, crouch periodically for prolonged periods of time; manipulation (lift, carry, move) of light to medium weights of 10-35 pounds; arm, hand and finger dexterity, including ability to grasp and type for prolonged periods of time; visual acuity to use a keyboard, computer monitor, operate equipment, and read materials for prolonged periods of time; ability to sit, reach with hands and arms, talk, and hear for prolonged periods of time.
Responsibilities
  • Maintains a basic understanding of industry and academic developments in biostatistical methodology, regulatory trends, and ophthalmology
  • Supports the development and rollout of new innovations, standards, processes, and efficiencies within Biostatistics
  • Provides scientific and technical consultation and collaborates with internal and external stakeholders to facilitate understanding of statistical services and product. Supports collaboration with Data Management.
  • Reviews clinical trial data and validates key endpoints or datasets
  • Represents Lexitas in interfaces with Sponsors and vendors
  • Ensures consistency and adherence to standards and departmental SOPs
  • Ensures the statistical integrity of all deliverables and authors appropriate sections of protocols, statistical analysis plans, CSRs, presentations, and publications of clinical trial data
  • Leads, manages, and supports statistical activities for clinical studies, submissions, and development initiatives
  • Tracks and escalates concerns related to changes in scope of services
  • Mentors junior biostatisticians

Lexitas Pharma Services is a clinical research organization focused exclusively on ophthalmology, helping biopharmaceutical and medical device companies advance eye-related products through clinical trials. It provides end-to-end ophthalmic trial services from strategy and protocol design to execution, data management, and analysis. Its niche focus lets it tailor study designs, imaging endpoints, regulatory considerations, and trial operations specifically for eye conditions, unlike generic CROs. Its goal is to help clients bring ophthalmic therapies and devices to market faster with high-quality data to support regulatory approvals and market access.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Durham, North Carolina

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • NAMSA partnership announced April 30, 2026, embeds Lexitas in end-to-end MedTech platform.
  • DiagnosTear TeaRx partnership enhances ophthalmic trial diagnostics.
  • Sriram Venkateswaran CFO appointment strengthens financial leadership for growth.

What critics are saying

  • Navitas Life Sciences undercuts Lexitas on costs, eroding market share in 6-12 months.
  • ORA's 200+ eye sites poach Lexitas' network, slashing execution edge in 12-18 months.
  • NAMSA integration commoditizes Lexitas' expertise, losing biopharma clients in 12-24 months.

What makes Lexitas unique

  • Lexitas specializes exclusively in ophthalmology CRO services since 2011.
  • In-house Reading Center provides integrated GCP-compliant image analysis.
  • 700+ investigator sites support anterior and posterior segment trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

Seeking Alpha
Feb 14th, 2024
Lexitas appoints Sriram Venkateswaran as CFO

Lexitas appoints Sriram Venkateswaran as CFO.

Global Advertising News
Sep 13th, 2023
Lexitas Pharma Services, Inc. Partners With DiagnosTear Ltd. For The Use Of TeaRx™ In Ophthalmic Clinical Trials

Lexitas Pharma Services, Inc. partners with DiagnosTear Ltd. for the use of TeaRx™ in ophthalmic clinical trials.

INACTIVE